Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranit Aharonov

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical & Experimental Metastasis|November 6, 2012
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumorsGeorge Pentheroudakis, Yael Spector, Dimitrios Krikelis, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Cancer Research|February 18, 2010
hsa-miR-29c* is linked to the prognosis of malignant pleural mesotheliomaHarvey I Pass, Chandra Goparaju, Sergey Ivanov, et al.
Nature Genetics|June 21, 2005
Identification of hundreds of conserved and nonconserved human microRNAsIsaac Bentwich, Amir Avniel, Yael Karov, et al.
Frontiers in Immunology|May 29, 2026
Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomicsBohdana Chayen, Gal Dinstag, Omer Tirosh, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
Ebiomedicine|June 23, 2016
Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam AntibioticsKeira A Cohen, Tal El-Hay, Kelly L Wyres, et al.
Molecular Cancer|June 14, 2013
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryGeorge Pentheroudakis, Nicholas Pavlidis, George Fountzilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primaryGauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Genome Research|December 3, 2004
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissuesOmer Barad, Eti Meiri, Amir Avniel, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical & Experimental Metastasis|November 6, 2012
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumorsGeorge Pentheroudakis, Yael Spector, Dimitrios Krikelis, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Cancer Research|February 18, 2010
hsa-miR-29c* is linked to the prognosis of malignant pleural mesotheliomaHarvey I Pass, Chandra Goparaju, Sergey Ivanov, et al.
Nature Genetics|June 21, 2005
Identification of hundreds of conserved and nonconserved human microRNAsIsaac Bentwich, Amir Avniel, Yael Karov, et al.
Frontiers in Immunology|May 29, 2026
Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomicsBohdana Chayen, Gal Dinstag, Omer Tirosh, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
Ebiomedicine|June 23, 2016
Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam AntibioticsKeira A Cohen, Tal El-Hay, Kelly L Wyres, et al.
Molecular Cancer|June 14, 2013
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryGeorge Pentheroudakis, Nicholas Pavlidis, George Fountzilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primaryGauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Genome Research|December 3, 2004
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissuesOmer Barad, Eti Meiri, Amir Avniel, et al.
Pageof 4